These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 22490676
1. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. Bougie DW, Rasmussen M, Zhu J, Aster RH. Blood; 2012 Jun 28; 119(26):6317-25. PubMed ID: 22490676 [Abstract] [Full Text] [Related]
2. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Blood; 2002 Sep 15; 100(6):2071-6. PubMed ID: 12200368 [Abstract] [Full Text] [Related]
3. An αIIb β3 antagonist prevents thrombosis without causing Fc receptor γ-chain IIa-mediated thrombocytopenia. Kuo YJ, Chen YR, Hsu CC, Peng HC, Huang TF. J Thromb Haemost; 2017 Nov 15; 15(11):2230-2244. PubMed ID: 28815933 [Abstract] [Full Text] [Related]
4. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site. Marcinkiewicz C, Vijay-Kumar S, McLane MA, Niewiarowski S. Blood; 1997 Aug 15; 90(4):1565-75. PubMed ID: 9269775 [Abstract] [Full Text] [Related]
9. Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. Basani RB, Zhu H, Thornton MA, Soto CS, Degrado WF, Kowalska MA, Bennett JS, Poncz M. Blood; 2009 Jan 22; 113(4):902-10. PubMed ID: 18987357 [Abstract] [Full Text] [Related]
12. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV. Biokhimiia; 1996 Mar 22; 61(3):412-28. PubMed ID: 8724599 [Abstract] [Full Text] [Related]
14. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond. Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF. Curr Drug Metab; 2016 Mar 22; 17(2):194-203. PubMed ID: 26652157 [Abstract] [Full Text] [Related]
15. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Peter K, Schwarz M, Ylänne J, Kohler B, Moser M, Nordt T, Salbach P, Kübler W, Bode C. Blood; 1998 Nov 01; 92(9):3240-9. PubMed ID: 9787160 [Abstract] [Full Text] [Related]
18. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling. Honda S, Tomiyama Y, Aoki T, Shiraga M, Kurata Y, Seki J, Matsuzawa Y. Blood; 1998 Nov 15; 92(10):3675-83. PubMed ID: 9808561 [Abstract] [Full Text] [Related]